174 related articles for article (PubMed ID: 33821278)
1. Analysis of glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein.
Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski J
bioRxiv; 2021 Apr; ():. PubMed ID: 33821278
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.
Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski JG
J Virol; 2022 Feb; 96(3):e0162621. PubMed ID: 34817202
[TBL] [Abstract][Full Text] [Related]
3. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
4. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.
Go EP; Herschhorn A; Gu C; Castillo-Menendez L; Zhang S; Mao Y; Chen H; Ding H; Wakefield JK; Hua D; Liao HX; Kappes JC; Sodroski J; Desaire H
J Virol; 2015 Aug; 89(16):8245-57. PubMed ID: 26018173
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity.
Zhang F; Schmidt F; Muecksch F; Wang Z; Gazumyan A; Nussenzweig MC; Gaebler C; Caskey M; Hatziioannou T; Bieniasz PD
bioRxiv; 2023 Jun; ():. PubMed ID: 37425700
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.
Li T; Zheng Q; Yu H; Wu D; Xue W; Xiong H; Huang X; Nie M; Yue M; Rong R; Zhang S; Zhang Y; Wu Y; Wang S; Zha Z; Chen T; Deng T; Wang Y; Zhang T; Chen Y; Yuan Q; Zhao Q; Zhang J; Gu Y; Li S; Xia N
Emerg Microbes Infect; 2020 Dec; 9(1):2076-2090. PubMed ID: 32897177
[TBL] [Abstract][Full Text] [Related]
7. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the
Balieu J; Jung JW; Chan P; Lomonossoff GP; Lerouge P; Bardor M
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014368
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
Kim CH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
[TBL] [Abstract][Full Text] [Related]
10. An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.
Guo Y; He W; Mou H; Zhang L; Chang J; Peng S; Ojha A; Tavora R; Parcells MS; Luo G; Li W; Zhong G; Choe H; Farzan M; Quinlan BD
mBio; 2021 May; 12(3):. PubMed ID: 33975938
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.
Grant OC; Montgomery D; Ito K; Woods RJ
Sci Rep; 2020 Sep; 10(1):14991. PubMed ID: 32929138
[TBL] [Abstract][Full Text] [Related]
12. Lentil lectin derived from
Wang W; Li Q; Wu J; Hu Y; Wu G; Yu C; Xu K; Liu X; Wang Q; Huang W; Wang L; Wang Y
Emerg Microbes Infect; 2021 Dec; 10(1):1519-1529. PubMed ID: 34278967
[TBL] [Abstract][Full Text] [Related]
13. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.
Zhao P; Praissman JL; Grant OC; Cai Y; Xiao T; Rosenbalm KE; Aoki K; Kellman BP; Bridger R; Barouch DH; Brindley MA; Lewis NE; Tiemeyer M; Chen B; Woods RJ; Wells L
bioRxiv; 2020 Jul; ():. PubMed ID: 32743578
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 S Glycoprotein Stabilization Strategies.
Pedenko B; Sulbaran G; Guilligay D; Effantin G; Weissenhorn W
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851772
[TBL] [Abstract][Full Text] [Related]
15. Small Structural Proteins E and M Render the SARS-CoV-2 Pseudovirus More Infectious and Reveal the Phenotype of Natural Viral Variants.
Wang HI; Chuang ZS; Kao YT; Lin YL; Liang JJ; Liao CC; Liao CL; Lai MMC; Yu CY
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445789
[TBL] [Abstract][Full Text] [Related]
16. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines.
Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
Ge J; Zhang S; Zhang L; Wang X
Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
19. A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters.
Margolin E; Schäfer G; Allen JD; Gers S; Woodward J; Sutherland AD; Blumenthal M; Meyers A; Shaw ML; Preiser W; Strasser R; Crispin M; Williamson AL; Rybicki EP; Chapman R
Front Plant Sci; 2023; 14():1146234. PubMed ID: 36959936
[TBL] [Abstract][Full Text] [Related]
20. The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses.
Ramírez Hernández E; Hernández-Zimbrón LF; Martínez Zúñiga N; Leal-García JJ; Ignacio Hernández V; Ucharima-Corona LE; Pérez Campos E; Zenteno E
Viral Immunol; 2021 Apr; 34(3):165-173. PubMed ID: 33605822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
